Therapy for Hepatitis C Virus (HCV) in Primary Treatment Failure in Pakistan

NCT05248919 · clinicaltrials.gov ↗

NA

Phase

ENROLLING_BY_INVITATION

Status

318

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis C

Interventions

DRUG: Epclusa (nucleotide HCV NS5B polymerase inhibitors).

Sponsor

Queen Mary University of London

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]